News
-
-
PRESS RELEASE
Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma
Xenetic Biosciences, Inc. collaborates with PeriNess Ltd. on a clinical study at Tel-Aviv Sourasky Medical Center to evaluate DNase I candidate XBIO-015 in osteosarcoma and Ewing sarcoma patients -
-
PRESS RELEASE
Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test
Applied DNA Sciences' ADCL seeks NYSDOH approval for PCR-based assay to detect H5 bird flu, leveraging PCR-based DNA technologies. Development initiated due to health concerns -
PRESS RELEASE
ALT5 Sigma to Exhibit at Transact Las Vegas April 2-4, 2025
ALT5 Sigma Corp. (NASDAQ:ALTS) to showcase blockchain-powered fintech solutions at Transact Las Vegas alongside key players in payments ecosystem. Event focuses on innovations in payment processing, digital assets, and blockchain -
-
-
-
-
